calendar
7,414 catalysts · 3,359 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
7,414 catalysts · 3,359 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE
Sponsor: NOVO NORDISK INC. Form: INJECTION. Route: SOLUTION
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL
Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Product code: QDQ. Advisory committee: Radiology. Type: Traditional
Product code: HAW. Advisory committee: Neurology. Type: Traditional
Product code: DYB. Advisory committee: Cardiovascular. Type: Special
Product code: HBE. Advisory committee: Neurology. Type: Traditional
Product code: LON. Advisory committee: Microbiology. Type: Traditional
Product code: OLO. Advisory committee: Neurology. Type: Special
Product code: CAW. Advisory committee: Anesthesiology. Type: Traditional
Product code: DXN. Advisory committee: Cardiovascular. Type: Traditional
Product code: QIH. Advisory committee: Radiology. Type: Traditional
Product code: QSM. Advisory committee: Gastroenterology, Urology. Type: Traditional
Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: QPT. Advisory committee: GU. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: MIH. Advisory committee: CV. Decision: APPR
CA grant. $215,976. PI: Kalyani Sonawane
DK grant. $43,313. PI: Elizabeth A Brown
CA grant. $521,002. PI: Luiz Eduardo Bertassoni
CA grant. $625,179. PI: Alexander E Davies
Sponsor: GENMAB US, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: HALEON US HOLDINGS. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMACEUTICALS, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: ACADIA PHARMS INC. Form: SOLUTION. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: SUBLINGUAL
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MANKIND PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: BIOGEN IDEC. Form: SOLUTION. Route: INTRATHECAL
Sponsor: IBSA INST BIO. Form: SYSTEM. Route: TOPICAL
Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION